Recall archive / FDA device enforcement
Bard Marquee Disposable Core Biopsy Instrument Kit: BARD MARQUEE KIT 12G X 10 CM, REF: MQK1210; BARD MARQUEE 12G X 10... — FDA record Z-0467-2025
Reported ongoing
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Sep 30, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Bard Marquee Disposable Core Biopsy Instrument Kit: BARD MARQUEE KIT 12G X 10 CM, REF: MQK1210; BARD MARQUEE 12G X 10 CM, REF: MQ1210; BARD MARQUEE Kit 12G X 13 CM, REF: MQK1213; BARD MARQUEE 12G X 13 CM, REF: MQ1213
- Reason
- Disposable biopsy instruments were potentially manufactured missing the backend notch retention feature on the needle that results in inadequate securing of the needle inside the device, which could lead to needle detachment and misplacement, which could lead to tissue damage and bleeding.
- Classification
- Class II
- Recalling firm
- Bard Peripheral Vascular Inc
- Quantity
- 71,498
- Agency-reported status
- Ongoing
- Source record identifier
- Z-0467-2025
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | REF/UDI-DI/Lot(Expiration): MQK1210/00801741097263/1490758(9/28/2025), 1506044(1/28/2026), 1506045(1/28/2026), 1511827(2/28/2026), 1514692(3/28/2026), 1518977(4/28/2026), 1518978(4/28/2026), 1518979(4/28/2026), 1519143(4/28/2026), 1520507(5/28/2026), 1520508(5/28/2026), 1522157(5/28/2026), 1522158(5/28/2026), 1522577(5/28/2026), 1523785(6/28/2026), 1523914(6/28/2026), 1523915(6/28/2026), 1525370(6/28/2026), 1525371(6/28/2026), 1525373(6/28/2026), 1528417(7/28/2026), 1528418(7/28/2026), 1528495(7/28/2026), 1528496(7/28/2026), 1528497(7/28/2026), 1528560(7/28/2026), 0001618867(3/28/2028), 0001620281(3/28/2028), 0001632675(6/28/2028); MQ1210/00801741097119/1514460(3/28/2026), 1514461(3/28/2026), 1519144(4/28/2026), 1519145(4/28/2026), 1519456(4/28/2026), 1520066(5/28/2026), 1520067(5/28/2026), 1520506(5/28/2026), 1523783(6/28/2026), 1523784(6/28/2026), 0001618258(3/28/2028), 0001631611(6/28/2028), 0001633216(7/28/2028); MQK1213/00801741097270/1543517(10/28/2026), 1559312(2/28/2027), 1562724(3/28/2027), 1569737(4/28/2027), 1581652(7/28/2027); MQ1213/00801741097126/1558191(2/28/2027), 1559313(2/28/2027) |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Worldwide - US Nationwide including in the states of WA, LA, MN, PA, UT, SC, OK, KY, AZ, IL, TX, NJ, NY, FL, TN, IN, OH, NC, CO, VA, GA, MD, CA, AL, WI, MO, IA, CT, NE, MI, MS, NV, KS, OR, SD, ID, NH, RI, WY, AR, MA, DE, ND, NM, AK, PR and the countries of Portugal, Spain, South Africa, Greece, United Arab Emirates, United Kingdom, Sweden, Finland, Belgium, Korea, Australia, Canada.
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
- Alaska
- Alabama
- Arkansas
- Arizona
- California
- Colorado
- Connecticut
- Delaware
- Florida
- Georgia
- Hawaii
- Iowa
- Idaho
- Illinois
- Indiana
- Kansas
- Kentucky
- Louisiana
- Massachusetts
- Maryland
- Maine
- Michigan
- Minnesota
- Missouri
- Mississippi
- Montana
- North Carolina
- North Dakota
- Nebraska
- New Hampshire
- New Jersey
- New Mexico
- Nevada
- New York
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Virginia
- Vermont
- Washington
- Wisconsin
- West Virginia
- Wyoming
Dates in the source
- Report date
- Nov 27, 2024
- Recall initiation date
- Sep 30, 2024
- Center classification date
- Nov 15, 2024
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.